Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Galvanize Therapeutics Partners with Energenx Medical for Greater China Expansion

December 16, 2024
CompanyDrug

AstraZeneca Launches Calquence in China for Mantle Cell Lymphoma Treatment

December 16, 2024
CompanyDeals

Kangtai Biological Partners with Indian Pharmaceutical Giant for 13-Valent Pneumonia Vaccine

December 16, 2024
CompanyDeals

Medtronic Launches AiBLE Orthopedic Ecosystem and Partners with Allinmd Orthopedics in China

December 16, 2024
CompanyDeals

TYK Medicines Partners with WuXi STA for Comprehensive CMC Services

December 16, 2024
CompanyDeals

Beijing’s E-Health Now Secures Tens of Millions in Series B Financing

December 16, 2024
CompanyDeals

Boyi Biotech Secures Over RMB100 Million in Series A Financing Led by JOLMO

December 16, 2024
CompanyDeals

Mindray Partners with Vazyme Biotech to Develop Automated Infection Screening Solutions

December 16, 2024
CompanyDrug

Hisun Pharmaceutical’s SHP2 Inhibitor HS336 Gets NMPA Clinical Trial Approval

December 16, 2024
Policy / Regulatory

Hainan Boao Lecheng Introduces 319 Overseas Drugs and Devices, Reports Significant Growth

December 16, 2024
Company

Moderna Establishes USD 100 Million Subsidiary in Shanghai to Expand mRNA Technology

December 16, 2024
DrugPolicy / Regulatory

Hubei Leads National Volume-Based Procurement of Patented Traditional Chinese Medicines

December 16, 2024
1 2 3 4 … 18 19
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up